ES512629A0 - Procedimiento para preparar una sal de pirimidona. - Google Patents

Procedimiento para preparar una sal de pirimidona.

Info

Publication number
ES512629A0
ES512629A0 ES512629A ES512629A ES512629A0 ES 512629 A0 ES512629 A0 ES 512629A0 ES 512629 A ES512629 A ES 512629A ES 512629 A ES512629 A ES 512629A ES 512629 A0 ES512629 A0 ES 512629A0
Authority
ES
Spain
Prior art keywords
pirimidone
salt
preparing
procedure
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES512629A
Other languages
English (en)
Spanish (es)
Other versions
ES8304094A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES8304094A1 publication Critical patent/ES8304094A1/es
Publication of ES512629A0 publication Critical patent/ES512629A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Air-Conditioning For Vehicles (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES512629A 1981-05-30 1982-05-28 Procedimiento para preparar una sal de pirimidona. Granted ES512629A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8116615 1981-05-30

Publications (2)

Publication Number Publication Date
ES8304094A1 ES8304094A1 (es) 1983-02-16
ES512629A0 true ES512629A0 (es) 1983-02-16

Family

ID=10522169

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512629A Granted ES512629A0 (es) 1981-05-30 1982-05-28 Procedimiento para preparar una sal de pirimidona.

Country Status (12)

Country Link
US (1) US4450161A (2)
EP (1) EP0067579B1 (2)
JP (1) JPS57206683A (2)
AT (1) ATE9345T1 (2)
AU (1) AU8431082A (2)
DE (1) DE3260719D1 (2)
DK (1) DK230482A (2)
ES (1) ES512629A0 (2)
GB (1) GB2112380A (2)
GR (1) GR76450B (2)
PT (1) PT74958B (2)
ZA (1) ZA823766B (2)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones

Also Published As

Publication number Publication date
DK230482A (da) 1982-12-01
ATE9345T1 (de) 1984-09-15
EP0067579A1 (en) 1982-12-22
PT74958B (en) 1983-12-23
US4450161A (en) 1984-05-22
DE3260719D1 (en) 1984-10-18
GB2112380A (en) 1983-07-20
ES8304094A1 (es) 1983-02-16
GR76450B (2) 1984-08-10
AU8431082A (en) 1982-12-09
JPS57206683A (en) 1982-12-18
EP0067579B1 (en) 1984-09-12
ZA823766B (en) 1983-04-27
PT74958A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
CO4820391A1 (es) Compuestos hipolipidemicos de benzotiazepina
DK502781A (da) Fremgangsmaade til fremstilling af 3-aryloxy-3-phenylpropylaminer
CY1107238T1 (el) Παρασκευη μιας πολυμορφικης μορφης ενος παραγωγου θειαζολιδινοδιονης
IT1171880B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
DK160092C (da) Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolin eller ikke-toxiske syreadditionssalte deraf
GB2123830A (en) Trisubstituted diazo compounds
IE790364L (en) 2-nitro aminopyrimidone derivatives
JPS5553288A (en) Heterocyclic derivative*its manufacture and medical composition containing it and having secretion controlling activity
DK163360C (da) Fremgangsmaade til fremstilling af krystallinske vandoploeselige salte af cefodizim
ES512629A0 (es) Procedimiento para preparar una sal de pirimidona.
DK355081A (da) 7-beta-(alfa-syn-methoxyimino-alfa(2-aminothiazol-4-yl) acetamido)-3-( (1,2,3-triadiazol-5-ylthio) methyl)-3-cephem-4-carboxylsyre samt c1-c6-alkylderivater heraf fremgangsmaade til fremstilling heraf samt deres anvendelse som antibakterielle midler
IT1206130B (it) Composti per abbassare i livelli dei lipidi.
DK15290A (da) Cholestadienderivat som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
AU545216B2 (en) 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol
ES500980A0 (es) Procedimiento de preparar alcoxi propanolaminas
IT8221939A0 (it) Immidazolil-propionitrili, procedimento per la preparazione di questi composti nonche' mezzi biocidi che li contengono.
ES499864A0 (es) Procedimiento para la preparacion de nuevas cefalosporinas
PT86610A (pt) Process for the preparation of a fungicidal compound containing 1-aminoethyl-3-aryl-4-cyano-pyrroles
ES8504829A1 (es) Un procedimiento para la preparacion de un acido -hidroxietilfosfinico
SE8107680L (sv) Piperazinderivat och forfarande for framstellning derav
ES541539A0 (es) Un procedimiento de preparar una sal de 3-amino-5-(2-((2-guanidino-4-tiazolil)-metiltio)-etilamino)-4-metil-1,2,4,6-tiatriazino-1-1-dioxido.
ES511869A0 (es) Procedimiento para preparar derivados de acido 5-aminometil-2,3-dihidro-2-oxo-1h-imidazol-4-carboxilico.
RO82161A (ro) Procedeu pentru prepararea 2-(2-clor-4-ciclopropilfenilimino)-imidazolidinei
FI832246A0 (fi) Foerfarande foer framstaellning av n-/2-(((5-(dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl/-n'-metyl-2-nitro-1,1-etendiamin